Lymphoscintigraphy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Condition:   Oropharynx Cancer Interventions:   Radiation: Radiation therapy (5 days for 7 weeks);   Radiation: Radiation therapy (5 days for 6 weeks);   Drug: Cisplatin Sponsors:   Fox Chase Cancer Center;   Cardinal Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials